Atherosclerotic Renovascular Disease: Epidemiology and Clinical Manifestations

  • James Ritchie
  • Philip A. KalraEmail author


Atherosclerotic renovascular disease (ARVD) is a frequently occurring condition, most commonly observed in patients with other macrovascular diseases. The presence of ARVD is associated with a significantly increased risk for cardiovascular morbidity and mortality. Although factors associated with systemic atheroma are implicated in the development of ARVD, the subsequent evolution of hypertension and renal impairment is more complex, with both whole organ and local factors playing important roles.


Atherosclerotic renovascular disease Epidemiology Presentation Prevalence Prognosis Progression Renal artery stenosis Risk factors 



Acute kidney injury


Atherosclerotic renovascular disease


Coronary artery disease


Chronic heart failure


Chronic kidney disease


Doppler ultrasound


Flash pulmonary edema


Peripheral vascular disease


Renin angiotensin aldosterone system


Renal artery stenosis


Randomized controlled trial


United States Renal Data System


  1. 1.
    De Bruyne B, Manoharan G, Pijls NHJ, Verhamme K, Madaric J, Bartunek J, Vanderheyden M, Heyndrickx GR. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Conlon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, McCants CB, Mark DB, Bashore TM, Albers F. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9:252–6.PubMedGoogle Scholar
  3. 3.
    Hietala SO, Kunz R. Collateral circulation in stenosis or occlusion of the renal artery. Cardiovasc Radiol. 1979;2:249–55.PubMedCrossRefGoogle Scholar
  4. 4.
    Eliska O. Blood flow through the collateral circulation of the kidney. Angiologica. 1966;3:333–42.PubMedGoogle Scholar
  5. 5.
    Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443–51.PubMedCrossRefGoogle Scholar
  6. 6.
    Lorenz EC, Vrtiska TJ, Lieske JC, Dillon JJ, Stegall MD, Li X, Bergstralh EJ, Rule AD. Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol. 2010;5:431–8.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen S-C, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293–301.PubMedCrossRefGoogle Scholar
  8. 8.
    Kalra PA, Guo H, Gilbertson DT, Liu J, Chen S-C, Ishani A, Collins AJ, Foley RN. Atherosclerotic renovascular disease in the United States. Kidney Int. 2009;77:37–43.CrossRefGoogle Scholar
  9. 9.
    Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau L-W, McBean M. Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. 2010;55:A6–7.CrossRefGoogle Scholar
  10. 10.
    ASTRAL Investigators, Wheatley K, Ives N, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Jazrawi A, Darda S, Burke P, Daccarett M, Stehlik J, David S, Zughaib M. Is race a risk factor for the development of renal artery stenosis? Cardiol Res Pract. 2009;2009:817987.PubMedCentralPubMedGoogle Scholar
  12. 12.
    Alhaddad IA, Blum S, Heller EN, Beato MA, Bhalodkar NC, Keriaky GE, Brown EJ. Renal artery stenosis in minority patients undergoing diagnostic cardiac catheterization: prevalence and risk factors. J Cardiovasc Pharmacol Ther. 2001;6:147–53.PubMedCrossRefGoogle Scholar
  13. 13.
    Tanemoto M, Saitoh H, Satoh F, Satoh H, Abe T, Ito S. Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. Hypertens Res. 2005;28:237–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Kawarada O, Yokoi Y, Morioka N, Takemoto K. Renal artery stenosis in cardio-and cerebrovascular disease: renal duplex ultrasonography as an initial screening examination. Circ J. 2007;71:1942–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Stimpel M, Groth H, Greminger P, Lüscher TF, Vetter H, Vetter W. The spectrum of renovascular hypertension. Cardiology. 1985;72 Suppl 1:1–9.PubMedCrossRefGoogle Scholar
  16. 16.
    de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009;27:1333–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Börgel J, Springer S, Ghafoor J, et al. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol. 2010;99:499–506.PubMedCrossRefGoogle Scholar
  18. 18.
    Paven G, Waugh R, Nicholson J, Gillin A, Hennessy A. Screening tests for renal artery stenosis: a case-series from an Australian tertiary referral centre. Nephrology (Carlton). 2006;11:68–72.CrossRefGoogle Scholar
  19. 19.
    Guo H, Kalra PA, Gilbertson DT, Liu J, Chen SC, Collins AJ, Foley RN. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation. 2006;115:50–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int. 1995;48:171–6.PubMedCrossRefGoogle Scholar
  21. 21.
    van Ampting JMAJ, Penne ELE, Beek FJAF, Koomans HAH, Boer WHW, Beutler JJJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant. 2003;18:1147–51.PubMedCrossRefGoogle Scholar
  22. 22.
    Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashore TM. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2:1608–16.PubMedGoogle Scholar
  23. 23.
    Khosla S, Kunjummen B, Manda R, et al. Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography. Catheter Cardiovasc Interv. 2003;58:400–3.PubMedCrossRefGoogle Scholar
  24. 24.
    Ollivier R, Boulmier D, Veillard D, Leurent G, Mock S, Bedossa M, Le Breton H. Frequency and predictors of renal artery stenosis in patients with coronary artery disease. Cardiovasc Revasc Med. 2009;10:23–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Cohen MG, Pascua JA, Garcia-Ben M, et al. A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization. Am Heart Assoc. 2005;150:1204–11.CrossRefGoogle Scholar
  26. 26.
    Rigatelli G, Roncon L, Rinuncini M, Giordan M, Bedendo E, Panin S, Rigatelli G, Zonzin P. Angiographic characteristics of renal arterial disease over the spectrum of coronary artery disease. Am J Nephrol. 2005;25:116–20.PubMedCrossRefGoogle Scholar
  27. 27.
    Wang Y, Ho DSW, Chen WH, Wang YQ, Lam WF, Shen ZJ, Lu CZ, Chui M. Prevalence and predictors of renal artery stenosis in Chinese patients with coronary artery disease. Intern Med J. 2003;33:280–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Rihal CS, Textor SC, Breen JF, McKusick MA, Grill DE, Hallett JW, Holmes DR. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309–16.PubMedCrossRefGoogle Scholar
  29. 29.
    Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Uzu T, Inoue T, Fujii T, Nakamura S, Inenaga T, Yutani C, Kimura G. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis. 1997;29:733–8.PubMedCrossRefGoogle Scholar
  31. 31.
    MacDowall P, Kalra PA, O’Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998;352:13–6.PubMedCrossRefGoogle Scholar
  32. 32.
    de Silva R, Loh H, Rigby AS, Nikitin NP, Witte KKA, Goode K, Bhandari S, Nicholson A, Clark AL, Cleland JGF. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol. 2007;100:273–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Kuroda S, Nishida N, Uzu T, Takeji M, Nishimura M, Fujii T, Nakamura S, Inenaga T, Yutani C, Kimura G. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke. 2000;31:61–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Horita Y, Tadokoro M, Taura K, Mishima Y, Miyazaki M, Kohno S, Kawano Y. Relationship between carotid artery intima-media thickness and atherosclerotic renal artery stenosis in type 2 diabetes with hypertension. Kidney Blood Press Res. 2002;25:255–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88:46N–51.PubMedCrossRefGoogle Scholar
  36. 36.
    Valentine RJ, Myers SI, Miller GL, Lopez MA, Clagett GP. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography. Ann Vasc Surg. 1993;7:220–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Iglesias JI, Hamburger RJ, Feldman L, Kaufman JS. The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease. Am J Med. 2000;109:642–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Amighi J, Schlager O, Haumer M, Dick P, Mlekusch W, Loewe C, Böhmig G, Koppensteiner R, Minar E, Schillinger M. Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease. Eur J Clin Invest. 2009;39:784–92.PubMedCrossRefGoogle Scholar
  39. 39.
    Androes MP, Langan EM, Kalbaugh CA, Blackhurst DW, Taylor SM, Youkey JR. Is incidental renal arteriography justified in a population of patients with symptomatic peripheral arterial disease? Vasc Endovascular Surg. 2007;41:106–10.PubMedCrossRefGoogle Scholar
  40. 40.
    Leertouwer TC, Pattynama PM, van den Berg-Huysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int. 2001;59:1480–3.PubMedCrossRefGoogle Scholar
  41. 41.
    Swartbol P, Thorvinger BO, Pärsson H, Norgren L. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol. 1992;11:195–9.PubMedGoogle Scholar
  42. 42.
    Salmon P, Brown MA. Renal artery stenosis and peripheral vascular disease: implications for ACE inhibitor therapy. Lancet. 1990;336:321.PubMedCrossRefGoogle Scholar
  43. 43.
    Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis. 2009;52:184–95.PubMedCrossRefGoogle Scholar
  44. 44.
    Shurrab AE, Mamtora H, O’Donoghue D, Waldek S, Kalra PA. Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease. Br J Radiol. 2001;74:213–8.PubMedGoogle Scholar
  45. 45.
    Black HR, Cooper KA. Cigarette smoking and atherosclerotic renal artery stenosis. J Clin Hypertens. 1986;2:322–30.PubMedGoogle Scholar
  46. 46.
    Gambaro G, Verlato F, Budakovic A, Casara D, Saladini G, Del Prete D, Bertaglia G, Masiero M, Checchetto S, Baggio B. Renal impairment in chronic cigarette smokers. J Am Soc Nephrol. 1998;9:562–7.PubMedGoogle Scholar
  47. 47.
    Scoble JE, de Takats D, Ostermann ME, Connolly JO, Scott NR, Beeso JA, Poyser KH, Peters TJ, Sherwood RA. Lipid profiles in patients with atherosclerotic renal artery stenosis. Nephron. 1999;83:117–21.PubMedCrossRefGoogle Scholar
  48. 48.
    Hood B, Brolin I, Kjellbo H, Angervall G. Serum lipids in renal artery stenosis and other hypertensive states. I. Abdominal aorta, renal arteries and fasting serum lipid levels. Acta Med Scand. 1966;179:575–82.PubMedCrossRefGoogle Scholar
  49. 49.
    Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, März W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab. 2006;91:2542–7.PubMedCrossRefGoogle Scholar
  50. 50.
    Cheung CM, Patel A, Shaheen N, Cain S, Eddington H, Hegarty J, Middleton RJ, Cowie A, Mamtora H, Kalra PA. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107:c35–42.PubMedCrossRefGoogle Scholar
  51. 51.
    Keddis M, Garovic V, Bailey K. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrol Dial Transplant. 2010;25:3615–22.PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, Casadei A, Davidson RC, Strandness DE. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735–42.PubMedCrossRefGoogle Scholar
  53. 53.
    Paraskevas KI, Hamilton G, Cross JM, Mikhailidis DP. Atherosclerotic renal artery stenosis: association with emerging vascular risk factors. Nephron Clin Pract. 2008;108:c56–66.PubMedCrossRefGoogle Scholar
  54. 54.
    Dzielińska Z, Januszewicz A, Demkow M, et al. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens. 2007;25:663–70.PubMedCrossRefGoogle Scholar
  55. 55.
    Suresh M, Laboi P, Mamtora H, Kalra PA. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant. 2000;15:631–6.PubMedCrossRefGoogle Scholar
  56. 56.
    Wright J, Shurrab A, Cheung C, Waldek S, O’Donoghue D, Foley R, Mamtora H, Kalra P. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis. 2002;39:1153–61.PubMedCrossRefGoogle Scholar
  57. 57.
    Chade AR, Kelsen S. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease. Circ Cardiovasc Interv. 2010;3:376–83.PubMedCentralPubMedCrossRefGoogle Scholar
  58. 58.
    Iliescu R, Fernandez SR, Kelsen S, Maric C, Chade AR. Role of renal microcirculation in experimental renovascular disease. Nephrol Dial Transplant. 2010;25:1079–87.PubMedCentralPubMedCrossRefGoogle Scholar
  59. 59.
    Kang D-H, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13:806–16.PubMedCrossRefGoogle Scholar
  60. 60.
    Zhu X-Y, Chade AR, Rodriguez-Porcel M, Bentley MD, Ritman EL, Lerman A, Lerman LO. Cortical microvascular remodeling in the stenotic kidney: role of increased oxidative stress. Arterioscler Thromb Vasc Biol. 2004;24:1854–9.PubMedCrossRefGoogle Scholar
  61. 61.
    Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–79.PubMedCentralPubMedCrossRefGoogle Scholar
  62. 62.
    Wolf G. Angiotensin II, as a mediator of tubulointerstitial injury. Nephrol Dial Transplant. 2000;15 Suppl 6:61–3.PubMedCrossRefGoogle Scholar
  63. 63.
    Wolf K, Kurtz A, Pfeifer M, Höcherl K, Riegger GA, Krämer BK. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch. 2001;442:212–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Farmer CK, Cook GJ, Blake GM, Reidy J, Scoble JE. Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis. Nephrol Dial Transplant. 1999;14:2880–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Wright JR, Duggal A, Thomas R, Reeve R, Roberts IS, Kalra PA. Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant. 2001;16:765–70.PubMedCrossRefGoogle Scholar
  66. 66.
    Gandy SJ, Armoogum K, Nicholas RS, McLeay TB, Houston JG. A clinical MRI investigation of the relationship between kidney volume measurements and renal function in patients with renovascular disease. Br J Radiol. 2007;80:12–20.PubMedCrossRefGoogle Scholar
  67. 67.
    Ruggenenti P, Porrini EL, Gaspari F, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care. 2012;35:2061–8.PubMedCentralPubMedCrossRefGoogle Scholar
  68. 68.
    Urbieta-Caceres VH, Lavi R, Zhu X-Y, Crane JA, Textor SC, Lerman A, Lerman LO. Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney. Am J Physiol Renal Physiol. 2010;299:F135–40.PubMedCentralPubMedCrossRefGoogle Scholar
  69. 69.
    Chade AR, Rodriguez-Porcel M, Grande JP, Zhu X, Sica V, Napoli C, Sawamura T, Textor SC, Lerman A, Lerman LO. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis. Arterioscler Thromb Vasc Biol. 2003;23:1295–301.PubMedCrossRefGoogle Scholar
  70. 70.
    Tuttle KR. Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosis. Am J Kidney Dis. 2002;39:1321–2.PubMedCrossRefGoogle Scholar
  71. 71.
    Cheung CM, Chrysochou C, Shurrab AE, Buckley DL, Cowie A, Kalra PA. Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2010;25:1133–40.PubMedCrossRefGoogle Scholar
  72. 72.
    Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383–92.PubMedGoogle Scholar
  73. 73.
    Crowley JJ, Santos RM, Peter RH, Puma JA, Schwab SJ, Phillips HR, Stack RS, Conlon PJ. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart Assoc. 1998;136:913–8.CrossRefGoogle Scholar
  74. 74.
    Caps M, Perissinotto C, Zierler R, Polissar N. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866–72.PubMedCrossRefGoogle Scholar
  75. 75.
    Hoefield RA, Kalra PA, Baker P, Lane B, New JP, O’Donoghue DJ, Foley RN, Middleton RJ. Factors associated with kidney disease progression and mortality in a referred CKD population. Am J Kidney Dis. 2010;56:1072–81.PubMedCrossRefGoogle Scholar
  76. 76.
    Valluri A, Severn A, Chakraverty S. Do patients undergoing renal revascularization outside of the ASTRAL trial show any benefit? Results of a single centre observational study. Nephrol Dial Transplant. 2011;27:734–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Bax L, Woittiez A-JJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(840–8):W150–1.Google Scholar
  78. 78.
    Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J Am Soc Nephrol. 2005;16:2746–53.PubMedCrossRefGoogle Scholar
  79. 79.
    Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM. 2009;102:695–704.PubMedCrossRefGoogle Scholar
  80. 80.
    Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2010;25:813–20.PubMedCrossRefGoogle Scholar
  81. 81.
    Marcantoni C, Zanoli L, Rastelli S, et al. Effect of renal artery stenting on left ventricular mass: a randomized clinical trial. Am J Kidney Dis. 2012;60:39–46.PubMedCrossRefGoogle Scholar
  82. 82.
    Green D, Kalra PA. The heart in atherosclerotic renovascular disease. Front Biosci. 2012;4:856–64.CrossRefGoogle Scholar
  83. 83.
    Rimoldi SF, Yuzefpolskaya M, Allemann Y, Messerli F. Flash pulmonary edema. Prog Cardiovasc Dis. 2009;52:249–59.PubMedCrossRefGoogle Scholar
  84. 84.
    Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32:670–9.PubMedCentralPubMedCrossRefGoogle Scholar
  85. 85.
    Chrysochou C, Sinha S, Chalmers N, Kalra PR, Kalra PA. Anuric acute renal failure and pulmonary oedema: a case for urgent action. Int J Cardiol. 2009;132:e31–3.PubMedCrossRefGoogle Scholar
  86. 86.
    Hackam DG, Duong-Hua ML, Mamdani M, Li P, Tobe SW, Spence JD, Garg AX. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart Assoc. 2008;156:549–55.CrossRefGoogle Scholar
  87. 87.
    Chrysochou C, Foley RN, Young JF, Khavandi K, Cheung CM, Kalra PA. Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease. Nephrol Dial Transplant. 2011;27:1403–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Cooper C, Murphy T, Matsumoto A, Steffes M, Cohen D, Jaff M, Kuntz R, Jamerson K, Reid D, Rosenfield K. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart Assoc. 2006;152:59–66.CrossRefGoogle Scholar
  89. 89.
    Dechering DG, Kruis H, Adiyaman A, Thien T, Postma CT. Clinical significance of low-grade renal artery stenosis. J Intern Med. 2010;267:305–15.PubMedCrossRefGoogle Scholar
  90. 90.
    Cheung CM, Wright JR, Shurrab AE, Mamtora H, Foley RN, O’Donoghue DJ, Waldek S, Kalra PA. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J Am Soc Nephrol. 2002;13:149–57.PubMedCrossRefGoogle Scholar
  91. 91.
    Shurrab AE, MacDowall P, Wright J, Mamtora H, Kalra PA. The importance of associated extra-renal vascular disease on the outcome of patients with atherosclerotic renovascular disease. Nephron Clin Pract. 2003;93:C51–7.PubMedCrossRefGoogle Scholar
  92. 92.
    Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis. 1994;24:622–9.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2014

Authors and Affiliations

  1. 1.Department of Renal MedicineSalford Royal NHS Foundation TrustSalfordUK

Personalised recommendations